GlassScriptPhysician profile
Jisha Cherian Chacko
NPI 1073804944
$2,427.42
in general payments reported to CMS, 2019-2025
35 companies · $18.29 in 2025
The $18.29 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,143 · 2022: $579 · 2023: $590 · 2024: $97.91 · 2025: $18.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.99 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.57 | 2021-2024 | |
| Glaxosmithkline, LLC. | $265.30 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $205.81 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $161.98 | 2021-2024 | Farxiga, Airsupra |
| Astellas Pharma US INC | $142.95 | 2021-2023 | Veozah |
| Amgen INC. | $138.90 | 2021-2024 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $129.46 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.40 | 2021-2023 | Jardiance |
| Abbott Laboratories | $92.68 | 2021-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $92.08 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.19 | 2021-2023 | Cycloset |
| Biohaven Pharmaceuticals, INC. | $69.92 | 2021 | |
| Novartis Pharmaceuticals Corporation | $69.05 | 2021-2023 | |
| Biogen, INC. | $68.18 | 2021 | |
| Lilly USA, LLC | $67.37 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $49.19 | 2021 | |
| Radius Health, INC. | $44.16 | 2023 | Tymlos |
| Pfizer INC. | $43.46 | 2021 | |
| Lundbeck LLC | $39.84 | 2022-2023 | Vyepti |
| Melinta Therapeutics, LLC | $25.85 | 2021 | |
| Dexcom, INC. | $20.78 | 2023 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $19.30 | 2023 | Wavewriter Alpha Prime 16 |
| Nestle Healthcare Nutrition INC. | $17.74 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.62 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.34 | 2022 | |
| Intuitive Surgical, INC. | $16.96 | 2022 | |
| Scilex Pharmaceuticals INC. | $16.48 | 2021 | |
| Sunovion Pharmaceuticals INC. | $15.88 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.88 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.22 | 2022 | |
| Merck Sharp & Dohme LLC | $14.96 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.15 | 2021 | |
| Evoke Pharma, INC. | $13.72 | 2021 | |
| Allergan, INC. | $13.56 | 2021 | |
| Medtronic, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jisha Chacko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.